Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Grifols, S.A. (“Grifols” or the “Company”) (NASDAQ: GRFS).
About the Investigation
On January 9, 2024, Bloomberg reported that “Short seller Gotham City Research LLC published a report criticizing the financial reporting of Spanish blood plasma firm Grifols SA.” According to Bloomberg, the “70-page report” said “Grifols has artificially reduced leverage by consolidating earnings of units it doesn’t control and has overstated profit.” Further, “[i]n its report, Gotham City said the stock market ‘appears to fundamentally misunderstand the company.’ It said Grifols includes in its financial statements earnings from BPC Plasma and Haema, which are owned by Scranton Enterprises NV, an investment vehicle for the Grifols’ founding family and a group of former executives.” Shares traded down on this news.
Contact
If you have information concerning this investigation, please fill out the form on this page.
About Berman Tabacco
Since 1982, our firm has prosecuted hundreds of securities and antitrust complex cases. The firm and its attorneys have been recognized for their work on behalf of plaintiffs, including by Chambers USA, Benchmark Litigation, which has ranked the firm as Highly Recommended and a Top Ten Plaintiffs, The Legal 500, U.S. News & World Report-Best Lawyers, The Daily Journal, Lawdragon, Who’s Who Legal, and Super Lawyers.
The firm has offices in Boston, Massachusetts and San Francisco, California.
This notice may constitute attorney advertising.
Contact:
Berman Tabacco
Jay Eng, Esq.
One Liberty Square
Boston, Massachusetts
(800) 516-9926
Email: law@bermantabacco.com